These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8603847)

  • 1. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas.
    Streilein JW; Bradley D; Sano Y; Sonoda Y
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):413-24. PubMed ID: 8603847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege.
    Dana MR; Dai R; Zhu S; Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):70-7. PubMed ID: 9430547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products.
    Streilein JW; Bradley D
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2700-10. PubMed ID: 1894470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss and restoration of immune privilege in eyes with corneal neovascularization.
    Dana MR; Streilein JW
    Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2485-94. PubMed ID: 8933765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulators of immunological responses in the cornea and the anterior chamber of the eye.
    Jager MJ; Gregerson DS; Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():241-6. PubMed ID: 7556725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latanoprost does not affect immune privilege of corneal allografts.
    Wang M; Kitahara Y; Yoshida A; Hori J
    Exp Eye Res; 2008 Feb; 86(2):394-402. PubMed ID: 18187130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intraocular gamma-interferon on immunoregulatory properties of iris and ciliary body cells.
    Streilein JW; Cousins S; Bradley D
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2304-15. PubMed ID: 1607242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunobiology of Langerhans cells on the ocular surface. I. Langerhans cells within the central cornea interfere with induction of anterior chamber associated immune deviation.
    Williamson JS; DiMarco S; Streilein JW
    Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1527-32. PubMed ID: 3623837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J; Zhu SN; Streilein JW; Dana MR
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.
    Yoshida M; Takeuchi M; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
    Sonoda A; Sonoda Y; Muramatu R; Streilein JW; Usui M
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):790-8. PubMed ID: 10711695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis.
    Ohta K; Yamagami S; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2591-9. PubMed ID: 10937571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of experimental ocular inflammation on ocular immune privilege.
    Ohta K; Wiggert B; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.
    Hori J; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):720-6. PubMed ID: 11222533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 1alpha,25-dihydroxyvitamin D3 on Langerhans cell migration and corneal neovascularization in mice.
    Suzuki T; Sano Y; Kinoshita S
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):154-8. PubMed ID: 10634615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune privilege and immunogenicity reside among different layers of the mouse cornea.
    Hori J; Joyce NC; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3032-42. PubMed ID: 10967061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.